Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp has demonstrated a solid growth trajectory, evidenced by a 5% increase in organic sales, indicating robust demand for its chemical and plastic-based products. Notably, the healthcare segment has consistently outperformed, achieving double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Furthermore, positive trends are seen in four out of nine end markets, which together account for 40% of the company’s sales, suggesting a diversified revenue stream that could support future growth despite challenges in the consumer end market.

Avient Corp has experienced inconsistent organic sales growth, with a notable decline of approximately 2% in 1Q24, despite subsequent quarterly recoveries showing growth rates of 5% and 9%. The company faces significant challenges in demand for chemicals, which has been weakening since mid-2025, raising concerns about potential decreases in volume in the second half of 2025. While there may be some temporary benefits due to a declining dollar, the overall outlook appears negative given the fundamental demand weaknesses in the core markets and volatility in sales growth.